Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

被引：0
|
作者：
Xiangyu Kong
Yiqi Du
Guokun Wang
Jun Gao
Yanfang Gong
Lei Li
Zhuo Zhang
Jiaqi Zhu
Qing Jing
Yongwen Qin
Zhaoshen Li
机构：
[1] Second Military Medical University,Department of Gastroenterology, Changhai Hospital
[2] Second Military Medical University,Department of Cardiology, Changhai Hospital
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Pancreatic cancer; Serum microRNA; Biomarker; miR-196a;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：602 / 609
页数：7
相关论文
共 50 条
  • [41] Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers
    Li, Ni
    Lian, Jiangfang
    Zhao, Sheng
    Zheng, Dawei
    Yang, Xi
    Huang, Xiaoyan
    Shi, Xinbao
    Sun, Lebo
    Zhou, Qingyun
    Shi, Huoshun
    Xu, Guodong
    Incoom, Enchill Kojo
    Zhou, Jianqing
    Shao, Guofeng
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [42] High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
    Curia, Maria Cristina
    Fantini, Fabiana
    Lattanzio, Rossano
    Tavano, Francesca
    Di Mola, Francesco
    Piantelli, Mauro
    Battista, Pasquale
    Di Sebastiano, Pierluigi
    Cama, Alessandro
    BMC CANCER, 2019, 19 (1)
  • [43] High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
    Zhang, Lingfu
    Xiu, Dianrong
    Zhan, Jun
    He, Xiaokun
    Guo, Limei
    Wang, Jilian
    Tao, Ming
    Fu, Wei
    Zhang, Hongquan
    ONCOTARGETS AND THERAPY, 2016, 9 : 6719 - 6726
  • [44] Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Chatterjee, Deyali
    Katz, Matthew H.
    Rashid, Asif
    Wang, Hua
    Iuga, Alina C.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Lee, Jeffrey E.
    Pisters, Peter W.
    Crane, Christopher H.
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 409 - 417
  • [45] High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
    Huo, Yanmiao
    Yang, Minwei
    Liu, Wei
    Yang, Jianyu
    Fu, Xueliang
    Liu, Dejun
    Li, Jiao
    Zhang, Junfeng
    Hua, Rong
    Sun, Yongwei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [46] Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
    Yalu Zhang
    Qiaofei Liu
    Jingkai Liu
    Quan Liao
    Cancer Cell International, 21
  • [47] Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
    Weng, Shaofan
    Wang, Hua
    Chen, Weihong
    Katz, Matthew H.
    Chatterjee, Deyali
    Lee, Jeffrey E.
    Pisters, Peter W.
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) : 1336 - 1343
  • [48] Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study
    Jiang, Dawei
    Yuan, Xiangfei
    Ni, Jianqi
    Shen, Lan
    Cai, Min
    Xu, Liu
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [49] Serum-derived exosomal miR-7977 combined with miR-451a as a potential biomarker for pancreatic ductal adenocarcinoma
    Chen, Jia
    Zhang, Xue
    Zhang, Guanyi
    Zhu, Fan
    Liu, Weiwei
    BMC CANCER, 2025, 25 (01)
  • [50] Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
    Qian Dong
    Xiang-hong Yang
    Yao Zhang
    Wei Jing
    Li-qiang Zheng
    Yun-peng Liu
    Xiu-juan Qu
    World Journal of Surgical Oncology, 12
12345